Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
The liquidity profile of the organization is characterized by a consistent state where current liabilities exceed current assets, as indicated by ratios remaining below 1.00 throughout the reported period. A general trend of volatility is observed, with a period of improvement peaking in late 2024, followed by a sustained decline through the third quarter of 2026.
- Current Ratio Analysis
- The current ratio fluctuated between 0.77 and 0.82 during 2022 and 2023. A positive trend emerged in 2024, reaching a peak of 0.91 by September 30, 2024. However, this peak was followed by a gradual contraction, with the ratio descending to 0.74 by September 30, 2026, marking the lowest point in the analyzed timeframe.
- Quick Ratio Analysis
- The quick ratio closely mirrors the movements of the current ratio, suggesting that inventory or other less liquid current assets represent a minimal portion of the total current asset base. The ratio reached its maximum value of 0.83 in September 2024 before entering a downward trajectory that concluded at 0.66 in September 2026.
- Cash Ratio Analysis
- The cash ratio exhibited the most significant variance, peaking at 0.46 in September 2022. After a period of relative stability, a notable downward shift occurred starting in late 2023. The ratio reached a low of 0.24 by December 31, 2025, and ended the period at 0.25, indicating a reduction in the immediate cash buffer available to cover short-term obligations.
- Overall Liquidity Trajectory
- A correlated decline is observed across all three liquidity metrics starting from the first quarter of 2025. The synchronization of the decrease in the current, quick, and cash ratios suggests a systemic reduction in liquidity or an increase in short-term liabilities that outpaced the growth of liquid assets during the final two years of the period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Current Ratio
| Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Current assets | 85,595) | 86,860) | 91,127) | 90,582) | 95,067) | 93,699) | 96,285) | 85,779) | 92,258) | 92,038) | 88,942) | 78,437) | 91,905) | 89,869) | 93,895) | 69,069) | 82,937) | 68,356) | 69,029) | ||||||
| Current liabilities | 115,835) | 111,820) | 114,124) | 114,897) | 115,526) | 110,781) | 113,471) | 103,769) | 101,565) | 104,670) | 104,431) | 99,054) | 114,179) | 112,981) | 116,482) | 89,237) | 100,935) | 88,698) | 88,170) | ||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Current ratio1 | 0.74 | 0.78 | 0.80 | 0.79 | 0.82 | 0.85 | 0.85 | 0.83 | 0.91 | 0.88 | 0.85 | 0.79 | 0.80 | 0.80 | 0.81 | 0.77 | 0.82 | 0.77 | 0.78 | ||||||
| Benchmarks | |||||||||||||||||||||||||
| Current Ratio, Competitors2 | |||||||||||||||||||||||||
| Abbott Laboratories | 1.45 | 1.38 | 1.39 | 1.58 | 1.70 | 1.82 | 1.78 | 1.67 | 1.60 | 1.68 | 1.60 | 1.64 | 1.74 | 1.64 | 1.68 | 1.63 | 1.86 | 2.01 | 1.85 | ||||||
| Elevance Health Inc. | 1.47 | 1.52 | 1.48 | 1.54 | 1.56 | 1.44 | 1.43 | 1.45 | 1.50 | 1.49 | 1.37 | 1.44 | 1.41 | 1.44 | 1.43 | 1.40 | 1.35 | 1.36 | 1.36 | ||||||
| Intuitive Surgical Inc. | 3.33 | 4.96 | 4.61 | 4.87 | 4.73 | 5.17 | 4.98 | 4.07 | 4.30 | 5.15 | 5.55 | 4.76 | 5.31 | 5.22 | 5.26 | 4.40 | 5.10 | 5.36 | 5.22 | ||||||
| Medtronic PLC | 2.54 | 2.42 | 2.01 | 1.85 | 1.90 | 1.84 | 2.13 | 2.03 | 2.30 | 2.29 | 2.42 | 2.39 | 1.76 | 1.76 | 1.58 | 1.86 | 2.61 | 2.91 | 2.89 | ||||||
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q3 2026 Calculation
Current ratio = Current assets ÷ Current liabilities
= 85,595 ÷ 115,835 = 0.74
2 Click competitor name to see calculations.
The liquidity profile of the organization is characterized by a current ratio that consistently remains below 1.00 throughout the analyzed period, indicating that current liabilities exceed current assets. This sustained position suggests a strategic reliance on operational cash flows or short-term financing to meet immediate obligations rather than maintaining a high buffer of liquid assets.
- Current Assets Trends
- Current assets exhibited significant volatility, fluctuating between a low of 68,356 million USD in June 2022 and a peak of 96,285 million USD in March 2025. A general upward trajectory was observed from 2022 through early 2025, followed by a slight contraction toward 85,595 million USD by September 2026.
- Current Liabilities Trends
- Current liabilities demonstrated a parallel volatility, ranging from 88,170 million USD in March 2022 to a peak of 116,482 million USD in March 2023. While liabilities saw a temporary reduction toward the end of 2023, they trended upward again through 2025 and 2026, concluding at 115,835 million USD.
- Current Ratio Dynamics
- The current ratio showed a gradual improvement phase beginning in late 2022, rising from 0.77 to a period peak of 0.91 in September 2024. This peak represented the organization's strongest short-term liquidity position in the reported timeframe. However, this trend reversed after September 2024, with the ratio declining steadily to 0.74 by September 2026, marking the lowest liquidity level across the entire sequence.
The convergence of increasing current liabilities and stagnating current assets in the final quarters of the period resulted in the observed deterioration of the current ratio. The consistent gap between assets and liabilities suggests a structural approach to working capital management where liquidity is optimized closely against short-term requirements.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Quick Ratio
| Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Cash and cash equivalents | 25,845) | 28,585) | 28,001) | 24,365) | 27,210) | 28,596) | 30,717) | 25,312) | 32,400) | 26,286) | 28,414) | 25,427) | 38,915) | 41,813) | 41,913) | 23,365) | 38,845) | 24,612) | 25,482) | ||||||
| Short-term investments | 2,704) | 2,883) | 3,228) | 3,756) | 3,404) | 3,424) | 3,574) | 3,801) | 4,734) | 5,037) | 4,296) | 4,201) | 5,182) | 4,466) | 4,584) | 4,546) | 3,682) | 3,352) | 2,914) | ||||||
| Accounts receivable, net | 20,543) | 21,573) | 26,587) | 23,018) | 22,672) | 24,142) | 26,936) | 22,365) | 20,024) | 23,115) | 27,197) | 21,276) | 20,673) | 17,952) | 22,414) | 17,681) | 17,047) | 18,718) | 18,871) | ||||||
| Other current receivables, net | 27,577) | 24,722) | 24,588) | 29,697) | 32,762) | 28,582) | 26,022) | 26,089) | 27,461) | 26,762) | 19,284) | 17,694) | 17,752) | 16,131) | 14,696) | 12,769) | 13,684) | 12,439) | 11,994) | ||||||
| Assets under management | —) | —) | —) | —) | —) | —) | —) | —) | —) | 3,414) | 3,619) | 3,755) | 3,616) | 3,623) | 3,837) | 4,087) | 4,022) | 4,017) | 4,155) | ||||||
| Total quick assets | 76,669) | 77,763) | 82,404) | 80,836) | 86,048) | 84,744) | 87,249) | 77,567) | 84,619) | 84,614) | 82,810) | 72,353) | 86,138) | 83,985) | 87,444) | 62,448) | 77,280) | 63,138) | 63,416) | ||||||
| Current liabilities | 115,835) | 111,820) | 114,124) | 114,897) | 115,526) | 110,781) | 113,471) | 103,769) | 101,565) | 104,670) | 104,431) | 99,054) | 114,179) | 112,981) | 116,482) | 89,237) | 100,935) | 88,698) | 88,170) | ||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Quick ratio1 | 0.66 | 0.70 | 0.72 | 0.70 | 0.74 | 0.76 | 0.77 | 0.75 | 0.83 | 0.81 | 0.79 | 0.73 | 0.75 | 0.74 | 0.75 | 0.70 | 0.77 | 0.71 | 0.72 | ||||||
| Benchmarks | |||||||||||||||||||||||||
| Quick Ratio, Competitors2 | |||||||||||||||||||||||||
| Abbott Laboratories | 0.83 | 0.80 | 0.84 | 1.02 | 1.09 | 1.14 | 1.09 | 1.05 | 1.00 | 1.02 | 0.95 | 1.00 | 1.04 | 1.00 | 1.07 | 1.06 | 1.22 | 1.33 | 1.21 | ||||||
| Elevance Health Inc. | 1.34 | 1.38 | 1.32 | 1.41 | 1.43 | 1.32 | 1.31 | 1.32 | 1.34 | 1.32 | 1.23 | 1.30 | 1.29 | 1.32 | 1.31 | 1.27 | 1.21 | 1.22 | 1.23 | ||||||
| Intuitive Surgical Inc. | 2.28 | 3.58 | 3.20 | 3.72 | 3.42 | 3.90 | 3.73 | 3.00 | 3.21 | 3.94 | 4.31 | 3.83 | 4.44 | 4.36 | 4.30 | 3.56 | 4.19 | 4.49 | 4.40 | ||||||
| Medtronic PLC | 1.55 | 1.48 | 1.25 | 1.20 | 1.19 | 1.17 | 1.35 | 1.31 | 1.46 | 1.42 | 1.51 | 1.54 | 1.18 | 1.18 | 1.01 | 1.30 | 1.87 | 2.07 | 2.06 | ||||||
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q3 2026 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 76,669 ÷ 115,835 = 0.66
2 Click competitor name to see calculations.
The liquidity position over the analyzed period demonstrates a consistent trend where quick assets remain below the value of current liabilities, resulting in a quick ratio that stays below 1.0. While the ratio experienced a period of gradual improvement and peaked in 2024, a subsequent decline is observed through 2026.
- Quick Ratio Trends
- The quick ratio exhibited moderate stability between 0.70 and 0.77 throughout 2022 and 2023. A period of strengthening occurred in the first three quarters of 2024, reaching a peak of 0.83 by September 30, 2024. However, a steady downward trajectory followed, with the ratio falling to 0.66 by September 30, 2026, marking the lowest point in the analyzed timeframe.
- Quick Assets Performance
- Total quick assets showed significant volatility, fluctuating between a low of 62,448 million US dollars in December 2022 and a high of 87,444 million US dollars in March 2023. Assets generally remained within the 76,000 to 87,000 million US dollar range from 2023 through 2026, though a slight contraction is evident in the final quarters of 2026.
- Current Liabilities Growth
- Current liabilities demonstrated a general upward trend over the period. Starting at 88,170 million US dollars in March 2022, liabilities increased to a range between 110,000 and 116,000 million US dollars by 2025 and 2026. The growth in obligations has outpaced the growth of quick assets in the latter part of the period, contributing to the compression of the quick ratio.
- Liquidity Implications
- The sustained quick ratio below 1.0 indicates that the organization does not maintain sufficient highly liquid assets to cover all short-term obligations immediately. The decline toward 0.66 in late 2026 suggests an increasing reliance on other current assets or operational cash flow to meet current liabilities.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Cash Ratio
| Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Cash and cash equivalents | 25,845) | 28,585) | 28,001) | 24,365) | 27,210) | 28,596) | 30,717) | 25,312) | 32,400) | 26,286) | 28,414) | 25,427) | 38,915) | 41,813) | 41,913) | 23,365) | 38,845) | 24,612) | 25,482) | ||||||
| Short-term investments | 2,704) | 2,883) | 3,228) | 3,756) | 3,404) | 3,424) | 3,574) | 3,801) | 4,734) | 5,037) | 4,296) | 4,201) | 5,182) | 4,466) | 4,584) | 4,546) | 3,682) | 3,352) | 2,914) | ||||||
| Assets under management | —) | —) | —) | —) | —) | —) | —) | —) | —) | 3,414) | 3,619) | 3,755) | 3,616) | 3,623) | 3,837) | 4,087) | 4,022) | 4,017) | 4,155) | ||||||
| Total cash assets | 28,549) | 31,468) | 31,229) | 28,121) | 30,614) | 32,020) | 34,291) | 29,113) | 37,134) | 34,737) | 36,329) | 33,383) | 47,713) | 49,902) | 50,334) | 31,998) | 46,549) | 31,981) | 32,551) | ||||||
| Current liabilities | 115,835) | 111,820) | 114,124) | 114,897) | 115,526) | 110,781) | 113,471) | 103,769) | 101,565) | 104,670) | 104,431) | 99,054) | 114,179) | 112,981) | 116,482) | 89,237) | 100,935) | 88,698) | 88,170) | ||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Cash ratio1 | 0.25 | 0.28 | 0.27 | 0.24 | 0.26 | 0.29 | 0.30 | 0.28 | 0.37 | 0.33 | 0.35 | 0.34 | 0.42 | 0.44 | 0.43 | 0.36 | 0.46 | 0.36 | 0.37 | ||||||
| Benchmarks | |||||||||||||||||||||||||
| Cash Ratio, Competitors2 | |||||||||||||||||||||||||
| Abbott Laboratories | 0.27 | 0.31 | 0.40 | 0.54 | 0.53 | 0.54 | 0.53 | 0.56 | 0.52 | 0.52 | 0.47 | 0.53 | 0.54 | 0.57 | 0.66 | 0.66 | 0.74 | 0.75 | 0.65 | ||||||
| Elevance Health Inc. | 0.81 | 0.85 | 0.82 | 0.88 | 0.89 | 0.79 | 0.79 | 0.85 | 0.90 | 0.86 | 0.82 | 0.87 | 0.90 | 0.92 | 0.91 | 0.86 | 0.87 | 0.86 | 0.86 | ||||||
| Intuitive Surgical Inc. | 1.60 | 2.71 | 2.36 | 2.96 | 2.72 | 3.15 | 2.93 | 2.30 | 2.52 | 3.20 | 3.49 | 3.15 | 3.86 | 3.77 | 3.59 | 2.90 | 3.50 | 3.78 | 3.58 | ||||||
| Medtronic PLC | 0.88 | 0.84 | 0.70 | 0.70 | 0.67 | 0.66 | 0.76 | 0.74 | 0.85 | 0.80 | 0.87 | 0.88 | 0.77 | 0.79 | 0.63 | 0.85 | 1.26 | 1.37 | 1.36 | ||||||
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).
1 Q3 2026 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 28,549 ÷ 115,835 = 0.25
2 Click competitor name to see calculations.
An analysis of the liquidity position from March 31, 2022, through September 30, 2026, reveals a general contraction in the immediate liquidity buffer. The most significant trend is a long-term decline in the cash ratio, which indicates a reduced capacity to cover current liabilities using only cash and cash equivalents.
- Cash Asset Volatility
- Total cash assets exhibited significant fluctuations throughout the period. A period of accumulation peaked in March 2023 at 50,334 million US dollars, following a previous surge in September 2022. However, a subsequent downward trend emerged, with cash assets declining to a low of 28,121 million US dollars by December 31, 2025. While some recovery occurred in early 2026, the cash levels remained substantially lower than the peaks observed in 2022 and 2023.
- Current Liability Expansion
- Current liabilities showed a general upward trajectory, increasing from 88,170 million US dollars in March 2022 to 115,835 million US dollars by September 30, 2026. Although there were intermittent decreases, such as the drop to 99,054 million US dollars in December 2023, the overall trend reflects a growing volume of short-term obligations over the analyzed timeframe.
- Cash Ratio Deterioration
- The cash ratio, driven by the combination of declining cash assets and rising current liabilities, demonstrates a clear downward trend. The ratio peaked at 0.46 in September 2022 but entered a period of steady erosion starting in 2024. The ratio fell below 0.30 in December 2024 and reached a minimum of 0.24 by December 31, 2025. By the end of the period in September 2026, the ratio stood at 0.25, representing a notable decrease from the 0.37 observed at the start of the sequence.
The convergence of increasing short-term liabilities and diminishing cash reserves has led to a weakened immediate liquidity profile. The transition from a peak ratio of 0.46 to a concluding ratio of 0.25 suggests a strategic shift in cash management or an increase in operational obligations that outpaces the growth of the most liquid assets.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?